THE MODERN BIOHEALTH, WITH PERSPECTIVE.
Clinician-led care in Florida

PEPTIDE ATLAS / SKIN & HAIR / GHK-CU

EvidenceEarly human
Early human research exists. Larger and better-controlled studies may be needed.
RegulatoryFood supplement / cosmetic
A consumer-product category, not approval as a medicine. Formulation and route matter.
Corrections & editorial standards

GHK-Cu

Editorial visualization for skin & hair peptide research
THE SIGNAL MAP · SKIN & HAIR
ALSO KNOWN ASCopper tripeptide-1

A copper-binding cosmetic peptide with a very different risk profile when injected.

01CATEGORYSkin & hair
02REGULATORY STATUSFood supplement / cosmetic
03COMMON ROUTETopical cosmetic use; injectable products are unapproved
04REVIEW STANDARDProduct, indication and evidence

HOW TO USE THIS PAGE

Read the profile in the order that protects the decision.

  1. 01
    Verify what it is

    Confirm the exact molecule, route, regulatory lane and actual human evidence.

  2. 02
    Read the evidence limits

    Unsupported claims, contraindications and uncertainty come before any protocol.

  3. 03
    Build the monitoring plan

    Define the target, baseline checks, reassessment point and stop rules with a qualified clinician.

IMPORTANT STATUS CHECK

Topical cosmetic use does not establish injectable safety. Injectable GHK-Cu is not FDA-approved; FDA identifies potential safety risks and limited human safety data.

RESEARCH PASSPORT

The five facts to know first.

HUMAN EVIDENCEEarly human

Evidence strength for the context described on this page.

REGULATORY LANEFood supplement / cosmetic

Status is product-, formulation- and indication-specific.

CLINICAL CONTEXTIndividual evaluation required

Public education does not establish a personal treatment plan.

SOURCE PACK1 direct source links

Plus 1 research searches. A search link is not a cited study or proof of a claim.

TESTED ATHLETESVerify the exact ingredient.

Peptide hormones, growth factors and related substances may be prohibited.

Check Global DRO ↗
Know the review boundary.

Where present, the date above records an editorial content review, not medical approval or a live check of every claim. Follow the official product label and regulator links for current status. This page does not establish availability through Modern Bio.

How we describe evidence →

OVERVIEW

What GHK-Cu is.

A naturally occurring copper-binding tripeptide used in topical cosmetic products. Topical cosmetic use, compounded injection and research-grade powder should be treated as distinct categories.

HOW IT IS THOUGHT TO WORK

In laboratory models it influences extracellular matrix, wound signaling and gene expression. Human cosmetic outcomes are less certain than mechanistic marketing suggests.

EFFECTS & EVIDENCE

What the evidence supports—and what it does not.

SUPPORTED IN CONTEXT
  • May support appearance-focused skin formulations
  • Limited human evidence for hair or wound outcomes
NOT ESTABLISHED
  • Systemic rejuvenation
  • Safe injectable anti-aging
  • Clinically meaningful hair regrowth
  • That copper delivery is universally beneficial

Evidence grade: Early human. For an approved drug, “high” refers only to its labeled indication—not every off-label or wellness claim.

CLINICAL CONTEXT

The decision is individual.

Formulation and intended use matter. An oral or topical consumer product does not establish the safety of an injectable preparation.

What is the exact claim?

Identify the outcome, formulation and population actually studied.

What would change the decision?

Review benefits, uncertainty, contraindications and better-studied alternatives.

Who owns follow-up?

A treatment decision needs a responsible clinician, monitoring and a review date.

This public guide does not provide a dosing, injection or self-treatment protocol. Bring the source links and the exact product into a licensed clinical consultation.

MONITORING

What should be tracked.

  • Irritation, discoloration or dermatitis
  • Photography under consistent lighting for cosmetic claims

SAFETY

Risks, red flags and reasons to avoid it.

KNOWN OR PLAUSIBLE RISKS
  • Topical irritation or allergy
  • Injectable aggregation, immunogenicity and impurities
  • Limited human safety data for systemic use
AVOID / ESCALATE
  • Injection
  • Broken or infected skin unless a clinician directs care
  • Assuming cosmetic-ingredient status means injectable safety
Stop and seek careGet urgent medical help for trouble breathing, facial or throat swelling, chest pain, fainting, severe persistent abdominal pain, neurologic changes, severe hypoglycemia, uncontrolled vomiting or a prolonged painful erection.

CLINICIAN VISIT CHECKLIST

Six questions worth bringing with you.

01What exact product is this?

Molecule or analog, salt, concentration, route, manufacturer or compounder, lot and beyond-use date.

02What outcome are we treating?

Name the diagnosis or target, how it will be measured and the realistic time to reassess.

03Why this option?

Ask how it compares with FDA-approved, lower-risk or better-studied alternatives.

04Where did the dose come from?

Label, human trial, specialty guideline or clinic convention—and whether that route and formulation match.

05What is the monitoring plan?

Baseline checks, follow-up measures, interactions, pregnancy considerations and symptoms that mean stop.

06How is quality verified?

Pharmacy license, prescription, identity/potency testing, sterility controls and who handles a product complaint.

Do not improvise reconstitution or convert “units” without the exact concentration. Mixing, storage and beyond-use instructions are product-specific; confirm them with the dispensing pharmacy.

SOURCES & RESEARCH LINKS

Read the record yourself.

We prioritize official prescribing information, FDA regulatory material, registered trials and indexed biomedical literature. Vendor and community dosing protocols are excluded from this public source list. These are supporting reading links, not a completed claim-by-claim citation map. Search links can lead to changing results; their presence does not establish that a particular study supports this profile.

PRODUCTS & TREATMENT ACCESS

Choose a tested finished product.

AVAILABILITY

Widely available in cosmetics; injectable use is not FDA-approved.

MARKET REALITY

Route matters. A topical ingredient with modest cosmetic evidence does not become a proven systemic longevity therapy when placed in a vial.

MODERN BIO AVAILABILITY

Evaluate the finished product.

The Atlas does not offer product checkout or certify a product’s identity, testing or suitability. Oral and topical research does not establish injectable safety.

Read the supplement quality guide →

NEXT STEP

Return to skin & hair peptides.

Explore the category →

YOUR NEXT STEP

Ready for a clinician-led plan?

Clinical review determines the appropriate next step. No treatment is guaranteed.

THE CARE PATH

  1. We order your labs

  2. A licensed clinician reviews results and recommends a plan

  3. Rx sent directly to you when appropriate

Care depends on eligibility and clinical judgment. No prescription is guaranteed. This pathway is not a recommendation for the treatment or test discussed in this guide.

Start your lab reviewExplore free educational tools